Shedir Pharma Group Logo

Shedir Pharma Group

SHE | XMIL

Overview

Corporate Details

ISIN(s):
IT0005379620
LEI:
81560092B300849E9017
Country:
Italy
Address:
VIA BAGNULO, 95, 80063 PIANO DI SORRENTO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Shedir Pharma Group S.p.A. is a holding company operating in the pharmaceutical and nutraceutical sectors. The group specializes in the research, development, formulation, and commercialization of a diverse portfolio that includes food supplements, dermo-cosmetics, medical devices, and pharmaceuticals. Its integrated business model comprises specialized subsidiaries for R&D, intellectual property management, and commercialization in domestic and international markets. The company offers approximately 300 products across 15 therapeutic areas, with an emphasis on unique, patented formulations. Distribution is carried out through a dedicated network of exclusive sales agents targeting medical and pharmaceutical professionals. The company was listed on Borsa Italiana's Euronext Growth Milan (formerly AIM Italia) market in 2019.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Shedir Pharma Group. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-01-23 15:09
Delisting Announcement
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 165.5 KB
2025-01-13 17:33
Delisting Announcement
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 182.0 KB
2025-01-10 18:00
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 159.1 KB
2025-01-09 19:17
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 147.6 KB
2025-01-07 18:45
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 150.6 KB
2025-01-03 17:36
Regulatory News Service
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.6 KB
2024-12-27 17:49
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.4 KB
2024-12-20 17:49
M&A Activity
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 156.6 KB
2024-12-13 17:42
Declaration of Voting Results & Voting Rights Announcements
COMUNICAZIONE AVENTE AD OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALIT…
Italian 157.4 KB
2024-12-06 17:49
M&A Activity
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 137.0 KB
2024-11-29 18:20
Proxy Solicitation & Information Statement
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 340.2 KB
2024-11-29 18:18
Delisting Announcement
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 127.5 KB
2024-11-29 18:16
Prospectus
COMUNICAZIONE AVENTE A OGGETTO OFFERTA PUBBLICA DI ACQUISTO VOLONTARIA TOTALITA…
Italian 1.1 MB
2024-09-26 18:01
Interim Report
SHEDIR PHARMA GROUP - AL 30 GIUGNO 2024 FATTURATO ED EBITDA CONSOLIDATI IN AUME…
Italian 769.4 KB
2024-09-02 17:56
M&A Activity
Dymalife finalizza l'acquisizione di un Ramo d'Azienda
Italian 377.0 KB

Automate Your Workflow. Get a real-time feed of all Shedir Pharma Group filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Shedir Pharma Group via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK